Aller au contenu principal
Retour aux discussions

Prévenir, traiter et guérir le cancer avec le système immunitaire | Dr. Alex Marson

Healthcare
United States
Commencé March 13, 2026

Dr. Alex Marson, MD, PhD, is a professor of medicine at the University of California, San Francisco. We discuss the biology of the immune system and cancer, and everyday choices that can increase or decrease your cancer risk, several of which are surprising but all of which are actionable. We also discuss immunotherapy, including how engineered T-cells can be used to defeat childhood and adult cancers. Dr. Marson explains CRISPR and gene editing to cure diseases, and we address the ethical qu...

Articles sources

Ajouter une affirmation Analyse 0/5
Need to find a specific claim? Search all statements.
🗳️ Join the conversation
5 affirmations à voter • Your perspective shapes the analysis
📊 Progress to Consensus Analysis Need: 7+ participants, 20+ votes, 3+ votes per statement
Participants 0/7
Statements (7+ recommended) 5/7
Total Votes 0/20
💡 Progress updates live here. Final readiness is confirmed when all three requirements are met.

Your votes count

No account needed — your votes are saved and included in the consensus analysis. Create an account to track your voting history and add statements.

CLAIM Publié par will • Mar 13, 2026
Investir dans l'immunothérapie et l'édition génétique comme CRISPR est crucial pour faire progresser le traitement du cancer et réduire les taux de mortalité.
Traduit par IA · Voir l'original

Investing in immunotherapy and gene editing like CRISPR is crucial for advancing cancer treatment and reducing mortality rates.

Vote options for this statement: agree, disagree, or unsure
💬 Voir la discussion
Be first to respond
Vote to see results
CLAIM Publié par will • Mar 13, 2026
La précipitation à adopter les technologies d'édition génétique soulève des préoccupations éthiques qui pourraient compromettre la sécurité des patients et le consentement éclairé.
Traduit par IA · Voir l'original

The rush to adopt gene editing technologies raises ethical concerns that could compromise patient safety and informed consent.

Vote options for this statement: agree, disagree, or unsure
💬 Voir la discussion
Be first to respond
Vote to see results
CLAIM Publié par will • Mar 13, 2026
Bien que les choix de style de vie puissent influencer le risque de cancer, les avancées médicales comme l'immunothérapie doivent rester l'objectif principal pour un traitement efficace.
Traduit par IA · Voir l'original

While lifestyle choices can influence cancer risk, medical advancements like immunotherapy should remain the primary focus for effective treatment.

Vote options for this statement: agree, disagree, or unsure
💬 Voir la discussion
Be first to respond
Vote to see results
CLAIM Publié par will • Mar 13, 2026
Nous devons évaluer de manière critique les effets à long terme de l'édition génétique sur les générations futures avant de mettre en œuvre largement ces technologies en médecine.
Traduit par IA · Voir l'original

We must critically evaluate the long-term effects of gene editing on future generations before widely implementing these technologies in medicine.

Vote options for this statement: agree, disagree, or unsure
💬 Voir la discussion
Be first to respond
Vote to see results
CLAIM Publié par will • Mar 13, 2026
Les cellules T modifiées représentent une approche révolutionnaire du traitement du cancer, susceptible de changer le pronostic pour de nombreux patients.
Traduit par IA · Voir l'original

Engineered T-cells represent a revolutionary approach to treating cancer, potentially changing the prognosis for many patients.

Vote options for this statement: agree, disagree, or unsure
💬 Voir la discussion
Be first to respond
Vote to see results

💡 How This Works

  • • Add Statements: Post claims or questions (10-500 characters)
  • • Vote: Agree, Disagree, or Unsure on each statement
  • • Respond: Add detailed pro/con responses with evidence
  • • Consensus: After enough participation, analysis reveals opinion groups and areas of agreement

Society Speaks is open and independent. Your support keeps civic discussion free from advertising and commercial influence.

Support us